Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia
Crossref DOI link: https://doi.org/10.1186/s12888-017-1358-3
Published Online: 2017-06-02
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pilon, Dominic http://orcid.org/0000-0003-2380-1495
Muser, Erik
Lefebvre, Patrick
Kamstra, Rhiannon
Emond, Bruno
Joshi, Kruti
Funding for this research was provided by:
Janssen Scientific Affairs, LLC